Senseonics Holdings (SENS) Liabilities and Shareholders Equity (2014 - 2026)
Senseonics Holdings (SENS) reported Liabilities and Shareholders Equity of $102.9 million for Q1 2026, up 17.94% year-over-year from $87.2 million in Q1 2025, and down 18.54% on a QoQ basis from $126.3 million in Q4 2025.
Senseonics Holdings (SENS) has 13 years of Liabilities and Shareholders Equity data on file, last reported at $102.9 million in Q1 2026.
- Quarterly Liabilities and Shareholders Equity rose 17.94% year-over-year to $102.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $519.3 million (up 31.29% YoY) and the FY2025 annual result came in at $126.3 million, up 25.72% from the prior year.
- Liabilities and Shareholders Equity eased to $102.9 million in Q1 2026 per SENS's latest filing, from $126.3 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $188.1 million in Q1 2022 and bottomed at $87.2 million in Q1 2025.
- The 5-year median for Liabilities and Shareholders Equity is $139.9 million (2025), against an average of $139.4 million.
- The widest annual swing landed in 2024, when Liabilities and Shareholders Equity tumbled 37.47%; it then soared 45.25% in 2025.
- Tracing SENS's Liabilities and Shareholders Equity over 5 years: stood at $177.7 million in 2022, then slipped by 22.21% to $138.2 million in 2023, then slipped by 27.33% to $100.4 million in 2024, then rose by 25.72% to $126.3 million in 2025, then declined by 18.54% to $102.9 million in 2026.
- Per Business Quant, the three latest SENS Liabilities and Shareholders Equity figures stand at $102.9 million (Q1 2026), $126.3 million (Q4 2025), and $139.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Senseonics Holdings | 316.18 Mn | 251.85 Mn | 6.94 Mn | 102.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 102.86 Mn |
| Dec 31, 2025 | 126.27 Mn |
| Sep 30, 2025 | 139.92 Mn |
| Jun 30, 2025 | 150.27 Mn |
| Mar 31, 2025 | 87.21 Mn |
| Dec 31, 2024 | 100.44 Mn |
| Sep 30, 2024 | 96.33 Mn |
| Jun 30, 2024 | 111.56 Mn |
| Mar 31, 2024 | 126.52 Mn |
| Dec 31, 2023 | 138.22 Mn |
| Sep 30, 2023 | 154.07 Mn |
| Jun 30, 2023 | 153.36 Mn |
| Mar 31, 2023 | 158.53 Mn |
| Dec 31, 2022 | 177.67 Mn |
| Sep 30, 2022 | 182.67 Mn |
| Jun 30, 2022 | 175.33 Mn |
| Mar 31, 2022 | 188.10 Mn |
| Dec 31, 2021 | 198.93 Mn |
| Sep 30, 2021 | 219.62 Mn |
| Jun 30, 2021 | 235.13 Mn |
| Mar 31, 2021 | 195.95 Mn |
| Dec 31, 2020 | 35.92 Mn |
| Sep 30, 2020 | 44.06 Mn |
| Jun 30, 2020 | 40.84 Mn |
| Mar 31, 2020 | 35.27 Mn |
| Dec 31, 2019 | 132.80 Mn |
| Sep 30, 2019 | 167.05 Mn |
| Jun 30, 2019 | 98.40 Mn |
| Mar 31, 2019 | 129.40 Mn |
| Dec 31, 2018 | 159.97 Mn |
| Sep 30, 2018 | 183.33 Mn |
| Jun 30, 2018 | 208.67 Mn |
| Mar 31, 2018 | 77.82 Mn |
| Dec 31, 2017 | 45.94 Mn |
| Sep 30, 2017 | 60.14 Mn |
| Jun 30, 2017 | 47.16 Mn |
| Mar 31, 2017 | 16.23 Mn |
| Dec 31, 2016 | 22.27 Mn |
| Sep 30, 2016 | 28.01 Mn |
| Jun 30, 2016 | 38.68 Mn |
| Mar 31, 2016 | 39.28 Mn |
| Dec 31, 2015 | 5.42 Mn |
| Sep 30, 2015 | 1,807.00 |
| Jun 30, 2015 | 996.00 |
| Mar 31, 2015 | 14,729.00 |
| Dec 31, 2014 | 20.00 Mn |
| Sep 30, 2014 | 4,419.00 |
| Jun 30, 2014 | 10,000.00 |